Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
Clinical trial NCT00652275 · UNKNOWN
Trial details
- NCT number
- NCT00652275
- Sponsor
- African Malaria Network Trust
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.